U.S. Public Health Service Recommendations for Human Immunodeficiency Virus Counseling and Voluntary Testing for Pregnant Women

07-28-95 12:25PM FROM DHHS-OASH/OC TO 916199424979 P005/010

MMWR

July 7,1995

Use of AZT to Prevent Perinatal Transmission
(ACTG 076):
Workshop on Implications for Treatment,
Counseling, and HIV Testing
In February 1994, the National Institutes of Health announced interim results from
a multicenter, placebo-controlled clinical trial (AIDS Clinical Trials Group [ACTGJ protocol 076), indicating that administration of zidovudine (ZDV) to a selected group of
pregnant women infected with human immunodeficiency virus (HIV) and to their newborns reduced the risk for perinstel HIV transmission by approximately two thirds. On
June 6-7, 1994, the U.S. Public Health Service (PHS) convened a workshop in Bethesda, Maryland, to a) develop recommendations for the use of ZOV to reduce the
risk for perinatal HIV transmission and b) discuss the implications of these recommendations for treatment, counseling, and HIV testing of women and infants. PHS
published recommendations regarding ZDV therapy for pregnant women and their
newborns in August 1994.* The following persons either served as consultants at the
wqwrjtep for developingithe iecummerations for HIV counseling and voluntary test-.
ing for pregnant women or were members of the LUS. Public Health Service Task Fdrce
on the Use of Zidovudine to Reduce Perinatal Transmission of Human Immunodeficiency Virus.
Consultants

James R. Allen, M.D.. M.P.H.
American Medical Association
Chicago, IL
Arthur J. Ammann, M.D.
Pediatric AIDS Foundation
Novato, CA
Kela Ammons-Blenmen
Multicultural AIDS Coalition, Inc.
Boston, MA
Barbara Aranda-Naranjo, R.N., M.S.N.
The University of Texas Health Science
Center at SaaAntonio..
San Antonio, TX

Mary Beth Caschetta, MA.
HIV Law Project
New York, NY
Louis Z. Cooper, M.D.
St. Luke s-Roosevelt Hospital Center
New York, NY
Rosemary Davis
National Medical Association
Washington, DC
Clemente Diaz, M.D.
University of Puerto Rico Children's. Hmspial
San Juan, PR
Ana 0. Oumois, Ph.D.. D.S.W.
Community Family Planning Council
New York, NY

+_..

Marian D. Banzhaf'
New Jersey Women and AIDS Network
New Brunswick, NJ

*CDC. Recommendations of the U.S. Public Health Service Task Force on the Use of Zidovudine
to Reduce Perinstal Transmission of Human Immunodeficiency Virus. MMWR 1994;43
(No. RR-11)..

1"